A Study to Evaluate the Safety and Efficacy of PLM60 in Advanced HCC

NCT04331743 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Hepatocellular Carcinoma

Interventions

DRUG: Liposome-entrapped Mitoxantrone Hydrochloride Injection

Sponsor

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.